August 11, 2017
Seattle Children's Ben Towne Center for Childhood Cancer Research is actively fighting pediatric leukemia by harvesting and reprogramming a child's own T cells and using the immune system to fight cancer.
July 27, 2017
With 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) achieving complete initial remission in their PLAT-02 trial, researchers at Seattle Children’s are continuing to improve the experimental immunotherapy and reduce the rate of relapse.
July 12, 2017
Regulators have voted to approve America's first ever gene therapy for public use. An advisory panel of cancer experts at the Food and Drug Administration unanimously backed the one-time treatment at a meeting on Wednesday.